New Advances in COVID-19 Diagnostics | Clinical And Molecular Dx
The FDA has a site where people can check the expiration dates, and potential extensions on those dates, for at-home COVID-19 tests | Clinical And Molecular Dx
NeuroVoices: Richard Nowak, MD, MS, on the MINT Trial of Inebilzumab in Myasthenia Gravis
The director of the myasthenia gravis clinic at Yale University discussed the therapeutic potential of inebilizumab, an FDA-approved treatment for NMOSD, in myasthenia gravis, based on data from the phase 3 MINT study.
Factors associated with general practitioner‐led diagnosis of long COVID: an observational study using electronic general practice data from Victoria and New South Wales, Australia
Objectives To investigate associations between sociodemographic factors, pre-existing chronic comorbidities, and general practitioner-led diagnosis of long COVID. Design, setting, patients We cond...
Clinicians discussed the complexities of diagnosing Long COVID, emphasizing the need for improved biomarkers and diagnostic technologies to better serve affected patients.
Long Covid remains a challenge to diagnosis, according to new study
A new study has shown that lab tests may be 'unreliable' when it comes to diagnosing long Covid - as experts warn the need for 'quick and accurate' diagnosis is 'key'
Unmasking Long COVID Through Understanding Prevalence and Diagnosis
In our latest roundtable series, experts discussed Long COVID prevalence, underreporting, accurate diagnosis, and emphasized that Long COVID serves as an umbrella term.
Routine lab tests are not a reliable way to diagnose long COVID, finds study
A National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition. The study, part of NIH's Researching COVID to Enhance Recovery (NIH RECOVER) Initiative and published in the Annals of Internal Medicine, highlights how challenging it can be to identify and diagnose a novel illness such as long COVID.
Unmasking Long COVID Through Understanding Prevalence and Diagnosis
In our latest roundtable series, the discussion addressed Long COVID prevalence, underreporting, accurate diagnosis, and emphasized that Long COVID serves as an umbrella term.
A Long COVID Diagnosis: Implications for Social, Behavioral, and Economic Sciences
A Long COVID diagnosis has far-reaching impacts on individuals and communities. While most people recover fully from COVID-19, tens of millions continue
Medicine struggles to define chronic Lyme. Long Covid has only made it harder
The overlapping symptoms of long Covid and persistent Lyme challenge patients and doctors alike. Researchers are seeking biomarkers and devising "cross-illness" trials.
COVID-19 has killed more than 1 million Americans and 7 million throughout the world, but those numbers are dwarfed by the estimated 60 million worldwide suffering from long COVID. KYW medical editor Dr. Brian McDonough has more.
NIH: Routine Lab Tests Not a Reliable Way to Diagnose Long COVID
Since 2021, the US National Institutes of Health (NIH) has enrolled 90 000 people across more than 200 clinical sites as part of its RECOVER initiative to understand, identify, and treat post–COVID-19 condition, also known as long COVID. One goal of these studies has been to discover biomarkers that...
Randomized Controlled Trials for Post-COVID-19 Conditions: A Systematic Review
Post-coronavirus disease 2019 (COVID-19) syndrome or condition (PCS) is defined as new onset symptoms for at least three months following COVID-19 infection that has persisted for at least two m...